Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Reference Guide
  /  
21-Hydroxylase IgG + IgA
Sign up free to test for 
21-Hydroxylase IgG + IgA
.
One login for 30+ lab companies.

21-Hydroxylase IgG + IgA

Anti-21-hydroxylase antibodies, or 21OH-autoantibodies, are key markers for autoimmune Addison's disease, the primary cause of adrenal insufficiency in the Western world.  These autoantibodies target the 21-hydroxylase enzyme, essential for steroid hormone synthesis. 

IgG and IgA anti-21-hydroxylase antibodies are subtypes of the anti-21-hydroxylase antibody group.  

The presence of these antibodies signifies the autoimmune destruction of the adrenal cortex, leading to deficiencies in glucocorticoids, mineralocorticoids, and sex steroids. 

Detection of anti-21-hydroxylase IfG and IgA antibodies through immunofluorescence, immunoprecipitation, or ELISA is crucial for diagnosing autoimmune adrenal insufficiency, often associated with other autoimmune disorders like autoimmune polyglandular syndrome (APS).

What are Anti-21-Hydroxylase IgG and IgA Antibodies?

Anti-21-hydroxylase antibodies, also known as 21-hydroxylase autoantibodies or 21OH-autoantibodies, are autoantibodies directed against the enzyme 21-hydroxylase (CYP21A2).  

These autoantibodies are important markers for autoimmune Addison's disease, which is the most common cause of primary adrenal insufficiency in the Western world.  [2., 11.]

Anti-21-hydroxylase antibodies are associated with autoimmune destruction of the adrenal cortex, leading to Addison's disease.  [2., 11.] 

IgG and IgA anti-21-hydroxylase antibodies are two distinct classes of the group of antibodies known as anti-21-hydroxylase antibodies.  Studies have been done to assess for the classes of antibodies present in the autoimmune destruction of the adrenal cortex; the IgG and IgA classes have been associated with this process.  [8., 9., 10.]

Anti-Adrenal Antibodies  [1., 7.] 

A panel of antiadrenal antibodies may be run to assess for the presence of antibodies against adrenal cortical cells from all 3 zones.  

Antiadrenal antibodies play a crucial role in diagnosing autoimmune adrenal insufficiency, a condition where the body's immune system attacks the adrenal glands, leading to deficiencies in glucocorticoids, mineralocorticoids, and sex steroids. 

This autoimmunity is often associated with antibodies against the enzyme 21-hydroxylase, which is pivotal in steroid hormone synthesis.  

Autoimmune adrenalitis accounts for over 70% of primary adrenal insufficiency cases in industrialized nations, frequently presenting as Addison disease, often part of autoimmune polyglandular syndrome (APS) types I or II. 

These antibodies can be detected using immunofluorescence, immunoprecipitation, or ELISA tests, with the presence of anti-21-hydroxylase antibodies indicating a high likelihood of autoimmune adrenal insufficiency. 

This condition is characterized by adrenal enlargement and lymphocytic infiltration in early stages, progressing to adrenal atrophy and fibrosis in chronic cases. 

Patients with autoimmune adrenal insufficiency often have antibodies against other endocrine glands and may exhibit conditions like hypothyroidism or polycystic ovarian syndrome. 

Despite the significant impact of these antibodies on adrenal function, they are relatively rare, affecting 4 to 11 per 100,000 individuals, with varying prevalence based on geographic and demographic factors.

Symptoms of Addison’s Disease  [4.] 

While the clinical picture may vary somewhat, especially if other autoimmune processes are present, common symptoms of Addison’s Disease include: 

  • Hyperpigmentation (darkening) of the skin and mucous membranes, often preceding other symptoms
  • Generalized fatigue and weakness
  • Poor appetite and weight loss
  • Nausea, vomiting, and diarrhea
  • Dizziness and syncope (fainting) due to low blood pressure
  • Muscle aches (myalgias) and muscle weakness
  • Low blood pressure (hypotension) and orthostatic hypotension (dizziness upon standing)
  • Salt cravings
  • Abdominal pain
  • Irritability and depression
  • Loss of appetite
  • Hypoglycemia (low blood sugar)
  • Hyperkalemia (high potassium levels)

It's important to note that while hyperpigmentation is a common symptom, it may not be present in all cases or in the early stages of the disease.  Additionally, the onset of symptoms is often gradual and nonspecific, making the diagnosis challenging in some cases.

Lab Testing for Anti-21-Hydroxylase Abs

Detecting anti-21-hydroxylase antibodies is crucial for diagnosing autoimmune adrenal insufficiency, also known as Addison's disease. Several laboratory tests are available to assess the presence and levels of these autoantibodies.

Laboratory Test Information, Sample Collection and Preparation

Anti-21-Hydroxylase Abs are commonly assessed in serum.  Sample collection requires a venipuncture.  

Typically, no special preparation is required, although this should be confirmed with the ordering provider.  

Anti-21-Hydroxylase Ab Test Interpretation

Optimal Levels of Anti-21-Hydroxylase Abs

A positive finding signifies the presence of anti-21-hydroxylase antibodies, which is indicative of Addison’s disease, an autoimmune disease that destroys adrenal tissue; this may be isolated Addison’s disease, or part of Type I or Type II autoimmune polyglandular syndrome.  [1., 7.] 

Optimal levels of anti-21-hydroxylase antibodies are considered undetectable.  

Clinical Significance of Elevated Anti-21-Hydroxylase Abs

A finding of elevated anti-21-hydroxylase antibodies in serum is indicative of Addison’s disease, which may occur on its own or as part of Type I or Type II autoimmune polyglandular syndrome.  This finding requires further assessment by an endocrinologist.  [1., 7.] 

Anti-21-Hydroxylase Abs Related Biomarkers

In addition to anti-21-hydroxylase antibodies, several other biomarkers are commonly tested in the context of autoimmune adrenal insufficiency and related conditions.

Adrenocortical Autoantibodies  [7.] 

Adrenocortical autoantibodies are directed against various components of the adrenal cortex, including enzymes involved in steroidogenesis and other adrenal-specific antigens.  These enzymes work alongside the 21-hydroxylase enzyme to interconvert steroidal hormones in the adrenal gland.  

These autoantibodies can be detected in patients with autoimmune adrenal insufficiency, and their presence can aid in the diagnosis and monitoring of the disease.

Steroid Hormones  [7.] 

Measurement of steroid hormones such as cortisol, aldosterone, and renin, can provide valuable information about the functional status of the adrenal glands. Abnormal levels of these hormones can indicate adrenal insufficiency or other adrenal disorders, and their assessment can complement the results of autoantibody testing.

Thyroid Autoantibodies

Autoimmune adrenal insufficiency is often associated with other autoimmune disorders, particularly autoimmune thyroid diseases.  [1., 7.]  

Testing for thyroid autoantibodies, such as anti-thyroglobulin and anti-thyroid peroxidase antibodies, can help identify the presence of concomitant autoimmune thyroid disorders and guide appropriate management.

Tissue-Specific Autoantibodies

Depending on the clinical presentation and suspected involvement of other endocrine or non-endocrine tissues, testing for additional tissue-specific autoantibodies may be warranted. For example, in the context of autoimmune polyglandular syndromes, autoantibodies against insulin, gastric parietal cells, or other organ-specific targets may be relevant.

ACTH Levels  [5.] 

Addison's disease results from the impaired production of cortisol and aldosterone by the adrenal glands.  

The ACTH stimulation test is considered the gold standard for diagnosing primary adrenal insufficiency.  In this test, synthetic ACTH is administered, and the cortisol response is measured. 

In Addison's disease, the adrenal glands fail to produce adequate cortisol levels in response to ACTH stimulation, indicating their dysfunction.  

Additionally, measuring baseline ACTH levels can help differentiate between primary adrenal insufficiency (high ACTH levels) and secondary adrenal insufficiency (low ACTH levels).  By assessing both ACTH and cortisol levels, healthcare professionals can accurately diagnose Addison's disease and distinguish it from other forms of adrenal insufficiency 

Order Anti-21-Hydroxylase Antibody Testing

Click here to compare testing options and order testing for anti-21-Hydroxylase antibodies.  

What's 
21-Hydroxylase IgG + IgA
?
If Your Levels Are High
Symptoms of High Levels
If Your Levels are Low
Symptoms of Low Levels
See References

[1.] 082024: Antiadrenal Antibodies, Quantitative | Labcorp. www.labcorp.com. https://www.labcorp.com/tests/082024/antiadrenal-antibodies-quantitative

[2.] 21-Hydroxylase Antibodies: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online June 26, 2021. https://emedicine.medscape.com/article/2117914-overview

‌[3.] 504805: Adrenal 21-Hydroxylase Autoantibodies (Endocrine Sciences) | Labcorp. www.labcorp.com. Accessed June 6, 2024. https://www.labcorp.com/tests/504805/adrenal-21-hydroxylase-autoantibodies-endocrine-sciences

[4.] Addison Disease Clinical Presentation: History, Physical, Causes. emedicine.medscape.com. https://emedicine.medscape.com/article/116467-clinical

[5.] Addison Disease Workup: Laboratory Studies, Imaging Studies, Other Tests. Medscape.com. Published November 10, 2019. https://emedicine.medscape.com/article/116467-workup

[6.] Annamaria De Bellis, Falorni A, Stefano Laureti, et al. Time Course of 21-Hydroxylase Antibodies and Long-Term Remission of Subclinical Autoimmune Adrenalitis after Corticosteroid Therapy: Case Report. ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism. 2001;86(2):675-678. doi:https://doi.org/10.1210/jcem.86.2.7212

[7.] Antiadrenal Antibody: Reference Range, Interpretation, Collection and Panels. eMedicine. Published online November 17, 2023. Accessed June 6, 2024. https://emedicine.medscape.com/article/2086413-overview#a4

[8.] Bøe AS, Bredholt G, Knappskog PM, Hjelmervik TO, Mellgren G, Winqvist O, Kämpe O, Husebye ES. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1. Eur J Endocrinol. 2004 Jan;150(1):49-56. doi: 10.1530/eje.0.1500049. PMID: 14713279.

[9.] Ishii T, Kashimada K, Amano N, Takasawa K, Nakamura-Utsunomiya A, Yatsuga S, Mukai T, Ida S, Isobe M, Fukushi M, Satoh H, Yoshino K, Otsuki M, Katabami T, Tajima T. Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision). Clin Pediatr Endocrinol. 2022;31(3):116-143. doi: 10.1297/cpe.2022-0009. Epub 2022 Apr 10. PMID: 35928387; PMCID: PMC9297175.

[10.] Parlato F, Pisano G, Brillante M, Ferrone R, Cavalcanti MR, Cosentini E, Misiano G, Brai M, Bellastella A. Immunological pattern in patients with 21-hydroxylase deficiency. J Endocrinol Invest. 1994 Sep;17(8):635-9. doi: 10.1007/BF03349677. PMID: 7868802.

[11.] Wolff AB, Breivik L, Hufthammer KO, Grytaas MA, Bratland E, Husebye ES, Oftedal BE. The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease. Eur J Endocrinol. 2021 Apr;184(4):607-615. doi: 10.1530/EJE-20-1268. PMID: 34665570; PMCID: PMC8052519. 

Test for

21-Hydroxylase IgG + IgA

Order, track, and receive results from 30+ labs in one place.